CynthiaJWetmoreMDPhD

PubMed

• 19 citations
  Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade glioma
  Chen He, Ke Xu, Xiaoyan Zhu, Paige S. Dunphy, Brian Gudenas, Wenwei Lin, Nathaniel R. Twarog, Laura D. Hover, Chang-Hyuk Kwon, Lawryn H. Kasper, Junyuan Zhang, Xiaoyu ...> ;Nature Communications. 2021 Jul 2
• 15 citations
  A phase 1 study of prexasertib (LY2606368), a CHK1/2 inhibitor, in pediatric patients with recurrent or refractory solid tumors, including CNS tumors: A report from th...
  Thomas Cash, Elizabeth Fox, Xiaowei Liu, Charles G. Minard, Joel M. Reid, Adrienne C. Scheck, Brenda J. Weigel, Cynthia Wetmore> ;Pediatric Blood & Cancer. 2021 Apr 21
• 2 citations
  Population Pharmacokinetics of Sunitinib and its Active Metabolite SU012662 in Pediatric Patients with Gastrointestinal Stromal Tumors or Other Solid Tumors.
  Erjian Wang, Steven G. DuBois, Cynthia Wetmore, Arnauld Verschuur, Reza Khosravan> ;European Journal of Drug Metabolism and Pharmacokinetics. 2021 Apr 14
• 4 citations
  Creation of a chemotherapy-induced nausea/vomiting dashboard to improve outcomes for pediatric cancer patients.
  Alexandra Walsh, Jennifer Hess, Melissa Rees, Cynthia Wetmore, Vinay Vadiya> ;Supportive Care in Cancer. 2021 Mar 1
• 8 citations
  Ad-CD40L mobilizes CD4 T cells for the treatment of brainstem tumors
  Phonphimon Wongthida, Matthew Schuelke, Christopher B. Driscoll, Timothy Kottke, Jill Thompson, Jason M. Tonne, Cathy Stone, Amanda L. Huff, Cynthia Wetmore, James A. ...> ;Neuro-Oncology. 2020 Dec 18
• 6 citations
  Population pharmacokinetics–pharmacodynamics of sunitinib in pediatric patients with solid tumors
  Erjian Wang, Steven G. DuBois, Cynthia Wetmore, Reza Khosravan> ;Cancer Chemotherapy and Pharmacology. 2020 Jul 4
• 19 citations
  A phase I study of sirolimus in combination with metronomic therapy (CHOAnome) in children with recurrent or refractory solid and brain tumors.
  Muna Qayed, Thomas Cash, Mourad Tighiouart, Tobey J. MacDonald, Kelly C. Goldsmith, Rachel Tanos, Leslie S. Kean, Benjamin Watkins, Yvonne Suessmuth, Cynthia Wetmore, ...> ;Pediatric Blood & Cancer. 2020 Apr 1
• 41 citations
  APOBEC3B-mediated Corruption of the Tumor Cell Immunopeptidome Induces Heteroclitic Neoepitopes for Cancer Immunotherapy
  Christopher B. Driscoll, Matthew Schuelke, Timothy Kottke, Jill Thompson, Phonphimon Wongthida, Jason M. Tonne, Amanda L. Huff, Amber Miller, Kevin G. Shim, Amy M. Mol...> ;Nature Communications. 2020 Feb 7
• 11 citations
  Physiologically Based Pharmacokinetic Modeling and Simulation of Sunitinib in Pediatrics
  Yanke Yu, Steven G. DuBois, Cynthia Wetmore, Reza Khosravan> ;The AAPS Journal. 2020 Jan 23
• 15 citations
  In vitro activity of a G-quadruplex-stabilizing small molecule that synergizes with Navitoclax to induce cytotoxicity in acute myeloid leukemia cells.
  Justin J. Montoya, Megan A. Turnidge, Daniel H. Wai, Apurvi R. Patel, David W. Lee, Vijay Gokhale, Laurence H. Hurley, Robert J. Arceci, Cynthia Wetmore, David O. Azorsa> ;BMC Cancer. 2019 Dec 27
• 7 citations
  Correction to: H3.3 K27M depletion increases differentiation and extends latency of diffuse intrinsic pontine glioma growth in vivo.
  Andre B. Silveira, Lawryn H. Kasper, Yiping Fan, Hongjian Jin, Gang Wu, Timothy I. Shaw, Xiaoyan Zhu, Jon D. Larson, John Easton, Ying Shao, Donald Yergeau, Celeste Ro...> ;Acta Neuropathologica. 2019 Apr 11
• 69 citations
  H3.3 K27M depletion increases differentiation and extends latency of diffuse intrinsic pontine glioma growth in vivo.
  Andre B. Silveira, Lawryn H. Kasper, Yiping Fan, Hongjian Jin, Gang Wu, Timothy I. Shaw, Xiaoyan Zhu, Jon D. Larson, John Easton, Ying Shao, Donald Yergeau, Celeste Ro...> ;Acta Neuropathologica. 2019 Feb 15
• 4 citations
  Opportunities for life course research through the integration of data across Clinical and Translational Research Institutes.
  Heidi A. Hanson, William W. Hay, Jonathan N. Tobin, Shari L. Barkin, Mark S. Atkins, Margaret R. Karagas, Ann Dozier, Cynthia Wetmore, Michael W. Konstan, James E. Heubi> ;Journal of Clinical and Translational Science. 2018 Jun 1
• 1 citations
  Forgoing Conventional Therapy in Phase I Oncology Research: Don't Forget About the Children.
  Cynthia Wetmore> ;The American Journal of Bioethics. 2017 Mar 22
• 3 citations
  Correlation of Ezrin Expression Pattern and Clinical Outcomes in Ewing Sarcoma.
  Thomas Cash, Hong Yin, Courtney McCracken, Zhi Geng, Steven G. DuBois, Bahig M. Shehata, Thomas A. Olson, Howard M. Katzenstein, Cynthia Wetmore> ;Sarcoma. 2017 Jan 26
• 48 citations
  Phase II evaluation of sunitinib in the treatment of recurrent or refractory high‐grade glioma or ependymoma in children: a children's Oncology Group Study ACNS1021
  Cynthia Wetmore, Vinay M. Daryani, Catherine A. Billups, James M. Boyett, Sarah Leary, Rachel Tanos, Kelly C. Goldsmith, Clinton F. Stewart, Susan M. Blaney, Amar Gajjar> ;Cancer Medicine. 2016 Jul 1
• 49 citations
  Alisertib is active as single agent in recurrent atypical teratoid rhabdoid tumors in 4 children
  Cynthia Wetmore, James M. Boyett, Shaoyu Li, Tong Lin, Anne Bendel, Amar Gajjar, Brent A. Orr> ;Neuro-Oncology. 2015 Jun 1
• 31 citations
  Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study
  Lindsey M. Hoffman, Maryam Fouladi, James M. Olson, Vinay M. Daryani, Clinton F. Stewart, Cynthia Wetmore, Mehmet Kocak, Arzu Onar-Thomas, Lars M. Wagner, Sridharan Gu...> ;Child's Nervous System. 2015 May 1
• 42 citations
  An open-label, two-stage, phase II study of bevacizumab and lapatinib in children with recurrent or refractory ependymoma: a collaborative ependymoma research network ...
  Mariko DeWire, Maryam Fouladi, David C. Turner, Cynthia Wetmore, Cynthia Hawkins, Carmen Jacobs, Ying Yuan, Diane Liu, Stewart Goldman, Paul G. Fisher, Michael Rytting...> ;Journal of Neuro-Oncology. 2015 Apr 10
• 32 citations
  Subsequent neoplasms in survivors of childhood central nervous system tumors: Risk after modern multimodal therapy
  Karen Tsui, Amar Gajjar, Chenghong Li, Deokumar Srivastava, Alberto Broniscer, Cynthia Wetmore, Larry E. Kun, Thomas E. Merchant, David W. Ellison, Brent A. Orr, Frede...> ;Neuro-Oncology. 2015 Mar 1
• 9 citations
  A phase 1 and pharmacokinetic study of enzastaurin in pediatric patients with refractory primary central nervous system tumors: a pediatric brain tumor consortium study.
  Lindsay Kilburn, Mehmet Kocak, Rodney Decker, Cynthia Wetmore, Murali Chintagumpala, Jack Su, Stewart Goldman, Anuradha Banerjee, Richard J. Gilbertson, Maryam Fouladi...> ;Neuro-Oncology. 2015 Feb 1
• 15 citations
  Pubertal development and primary ovarian insufficiency in female survivors of embryonal brain tumors following risk-adapted craniospinal irradiation and adjuvant chemo...
  Mariko DeWire, Daniel M. Green, Charles A. Sklar, Thomas E. Merchant, Dana Wallace, Tong Lin, Tamara Z. Vern-Gross, Larry E. Kun, Matthew J. Krasin, James M. Boyett, K...> ;Pediatric Blood & Cancer. 2015 Feb 1
• 42 citations
  Reirradiation of recurrent medulloblastoma: Does clinical benefit outweigh risk for toxicity?
  Cynthia Wetmore, Danielle Herington, Tong Lin, Arzu Onar-Thomas, Amar Gajjar, Thomas E. Merchant> ;Cancer. 2014 Dec 1
• 50 citations
  Evaluation of amifostine for protection against cisplatin-induced serious hearing loss in children treated for average-risk or high-risk medulloblastoma
  James G. Gurney, Johnnie K. Bass, Arzu Onar-Thomas, Jie Huang, Murali Chintagumpala, Eric Bouffet, Tim Hassall, Sridharan Gururangan, John A. Heath, Stewart J. Kellie,...> ;Neuro-Oncology. 2014 Jun 1
• 15 citations
  Feasibility and Efficacy of a Computer-Based Intervention Aimed at Preventing Reading Decoding Deficits Among Children Undergoing Active Treatment for Medulloblastoma:...
  Shawna L. Palmer, Laurie Leigh, Susan C. Ellison, Arzu Onar-Thomas, Shengjie Wu, Ibrahim Qaddoumi, Gregory T. Armstrong, Karen Wright, Cynthia Wetmore, Alberto Bronisc...> ;Journal of Pediatric Psychology. 2014 May 1
• Join now to see all

Journal Articles

• Phase I trial, pharmacokinetics and pharmacodynamics of vandetanib and dasatanib in children with newly diagnosed diffuse intrinsic pontine glioma  
  Broniscer A, Baker SD, Wetmore C, Pai-Panandiker A, Huang J, Davidoff AM, Onar-Thomas A, Panetta JC, Chin TK, Merchant TE, Baker JN, Kaste SC, Gajjar A, Stewart CF, Clin Cancer Res, 1/27/2013
• Determination of crenolanib in human serum and cerebrospinal fluid by liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS)  
  Roberts MS, Turner DC, Owens TS, Ramachandran A, Wetmore C, Throm SL, Stewart CF, J Chromatogr B Analyt Technol Biomed Life Sci, 1/15/2013
• Diffuse leptomemingeal gliomatosis  
  Jicha GA, Glantz J, Clarke MJ, Lehwald LM Russo DP, Giannini C, Wald JT, Uhm J, Kumar N, Aksamit AJ, Wetmore CJ, Eur Neurol, 1/1/2009
• Gli1-induces G2/M arrest in normal but not tumor-derived neural stem cells  
  Galvin KE, Ye H, Erstad DJ, Feddersen R, Wetmore C, Stem Cells, 1/1/2008
• Mouse embryos cloned from brain tumors  
  Li L, Connelly MC, Wetmore C, Curran T, Morgan JI, Cancer Res, 1/1/2003
• Reovirus prolongs survival and reduces the frequency of spinal and leptomeningeal metastases from medulloblastoma  
  Yang WQ, Senger D, Muzik H, Shi ZQ, Brasher PMA, Newcastle MB, Hamilton M, Wolff J, Wetmore C, Curran T, Lee PWK, Forsyth PA, Cancer Res, 1/1/2003
• A molecular fingerprint for medulloblastoma  
  Lee Y, Miller HL, Jensen P, Hernan R, Connelly M, Wetmore C, Zindy F, Roussel M, Curran T, Gilbertson R, McKinnon PJ, Cancer Res, 1/1/2003
• Prediction of central nervous system embryonal tumor outcome based on gene expression  
  Pomeroy SL, Tamayo P, Gaasenbeek M, Sturla LM, Angelo M, McLaughlin ME, Kim JYH, Goumnerova LC, Black PM, Lau C, Allen JC, Zagzag D, Olson JM, Curran T, Wetmore C, Bie..., Nature, 1/1/2002
• ERBB Receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease  
  Gilbertson RJ, Bentley L, Hernan R, Junttila TT, Frant AJ, Haapasalo H, Connelly M, Wetmore C, Curran T, Elenius K, Ellison DW, Clin Cancer Res, 1/1/2002
• Neuropathology of genetically engineered mice: consensus report and recommendations from an international forum  
  Weiss WA, Israel M, Cobbs C, Holland E, James CD, Louis DN, Marks C, McClatchey A, Roberts T, VanDyke T, Wetmore C, Chiu I, Giovannini M, Guha A, Higgins R, Marino S, ..., Oncogene, 1/1/2002
• Loss of p53 but not ARF accelerates medulloblastoma in mice heterozygous for patched  
  Wetmore C, Eberhart DE, Curran T, Cancer Res, 1/1/2001
• The normal patched allele is expressed in medulloblastomas from mice with heterozygous germline mutation of patched  
  Wetmore C, Eberhart DE, Curran T, Cancer Res, 1/1/2000
• Cellular hybridization for BDNF, trkB and NGF mRNAs and BDNF-immunoreactivity in rat forebrain after pilocarpine-induced status epilepticus  
  Schmidt-Kastner R, Humpel C, Wetmore C, Olson L, Exp Brain Res, 1/1/1996
• Cellular hybridization for BDNF, trkB and NGF mRNAs and BDNF-immunoreactivity in rat forebrain after pilocarpine-induced status epilepticus  
  Schmidt-Kastner R, Wetmore C, Olson L, Neuroscience, 1/1/1996
• Neuronal and non-neuronal expression of neurotrophins and their receptors in sensory and sympathetic ganglia of rat suggest new intercellular trophic interactions  
  Wetmore C, Olson L, J Comp Neurol, 1/1/1995
• Structural correlates and cellular mechanisms in entorhinal-hippocampal dysfunction  
  Schousboe A, Bachevalier J, Braak H, Heinemann U, Nitsch R, Schroder H, Wetmore C, Hippocampus, 1/1/1993
• High and low-affinity NGF receptor mRNAs in human foetal spinal cord and ganglia  
  Wetmore C, Bygdeman M, Olson L, Neuroreport, 1/1/1992
• Initial studies of embryonic transplants of human hippocampus and cerebral cortex derived from schizophrenic women  
  Freedman R, Strömberg I, Seiger A, Olson L, Nordstrom AL, Wiesel FA, Bygdeman M, Wetmore C, Palmer MR, Hoffer BJ, Biol Psychiatr, 1/1/1992
• Detection and characterization of sensory microganglion associated with the spinal accessory nerve  
  Wetmore C, Elde R, J Comp Neurol, 1/1/1991
• The nerve growth factor gene is expressed in both neuronal and non-neuronal tissues in the human embryo  
  Ernfors P, Wetmore C, Eriksdotter-Nilsson M, Bygdeman M, Strö'mberg I, Wetmore C, Olson L, Persson H, Int J Dev Neurosci, 1/1/1991
• Brain-derived neurotrophic factor: Subcellular compartmentalization and interneuronal transfer as visualized with anti-peptide antibodies  
  Wetmore C, Cao Y, Pettersson R, Olson L, Proc Natl Acad Sci, 1/1/1991
• Rescue of forebrain cholinergic neurons after implantation of genetically modified cells producing recombinant NGF  
  Strömberg I, Wetmore CJ, Ebendal T, Ernfors P, Persson H, Olson L, J Neurosci Res, 1/1/1990
• Grafts, growth factors and grafts that make growth factors In: Neural Transplantation: From Molecular Bases to Clinical Application  
  Olson L, Ayer-LeLievre C, Ebendal T, Eriksdotter-Nilsson M, Ernfors P, Henschen A, Hoffer B, Giacobini MB, Mouton P, Palmer M, Persson H, Sara V, Strömberg I, Wetmore C, Prog Brain Res, 1/1/1990
• Join now to see all

Books/Book Chapters

• Determined to Matter 
  Chapter: Book Afterward 
  O'Hara JHScarletta Press2013
• Principles & Practice of Neuro-oncology 
  Chapter: Brain tumor predisposition syndromes. 
  Foy AB, Wetmore CEditors: M. Mehta, et al.Demos Medical Publishing2010
• Principles of Neuro-oncology 
  Chapter: "The Phakomatoses" 
  Gutmann DH, Wetmore C, O'Neill BPEditors: David Schiff and Brian Patrick O'Neill.McGraw-Hill2005
• Research and Perspectives in Alzheimer's Disease 
  Chapter: Localizing expression of the three members of the NGF family to neurons in the brain. 
  Olson L, Wetmore C, Ernfors P, Ebendal T, Persson HEditors: Christen Y.Foundation EPSEN/Springer-Verlag1991
• Wenner-Gren Symposium "Volume Transmission." 
  Chapter: Endogenous and exogenous nerve growth factor in the central nervous system. 
  Olson L, Wetmore C, Strömberg I, Ebendal TEditors: Fuxe K.Raven Press1991
• Brain Repair, Wenner-Gren International Symposium Series. 
  Chapter: Strategies to increase NGF levels and effects thereof on lesioned and grafted brain tissue. 
  Page 87 - 98Olson L, Ebendal T, Eriksdotter-Nilsson M, Ernfors P, Friedman W, Persson H, Wetmore C, Strömberg IEditors: Björklund A, Aguayo A, Ottoson D.Macmillan, London, UK1990
• Growth Factors – From Genes to Clinical Application 
  Chapter: The expanding role of nerve growth factor in the central nervous system. 
  Page 167 - 177Olson L, Henschen A, Eriksdotter-Nilsson M, Str`mberg I, Wetmore C, Ernfors P, Friedman W, Persson H, Ebendal TEditors: Sara V, Hall K.Raven Press, New York, NY1990
• Join now to see all

Abstracts/Posters

• First in Pediatrics Phase I study of crenolanib (CP-868,596) administered during and after radiation therapy (RT) in newly-diagnosed diffuse intrinsic pontine glioma (...
  Wetmore, C., Broniscer, A., Wright, K., Armstrong, G., Baker, J., Kun, L., Patay, Z., Onar-Thomas, A., Ramachandran, A., Turner, D., Gajjar, A., Stewart, C, ASCO Annual Meeting, Chicago, IL, 1/1/2014
• A Phase I trial of MK-0752 in Pediatric Patients with Recurrent or Refractory CNS Malignancies: A Pediatric Brain Tumor Consortium Study.
  M. Fouladi, J. Olson, C.F. Stewart, M. Kocak, A. Onar-Thomas, L. Wagner, R. J. Packer, S. Goldman, S. Gururangan, S. M. Blaney, I. Pollack, C. Smith, A. Gajjar, T. Dem..., SNO Annual Meeting, 1/1/2013
• Activity of alisertib (MLN8237) as single agent in recurrent atypical teratiod tumor (ATRT) in four children: a single patient treatment plan pilot study.
  Wetmore C, Bendel A, Gajjar A, Rhabdoid Tumors: Integrating biological insights with clinical successes. Institut Curie, Paris, France, 1/1/2013
• Phase I study of crenolanib (CP-868,596) administered during and after radiation therapy (RT) in newly-diagnosed diffuse intrinsic pontine glioma (DIPG) and recurrent ...
  C Wetmore, A Broniscer, K Wright, G Armstrong, J Baker, A Pai-Panandiker, L Kun, Z Patay, A Onar-Thomas, A Ramachandran, D Turner, A Gajjar, C Stewart, ISPNO, Toronto, Canada, 1/1/2012
• Phase I study of crenolanib (CP-868,596) administered during and after radiation therapy (RT) in newly-diagnosed diffuse intrinsic pontine glioma (DIPG) and recurrent ...
  Wetmore, C., Broniscer, A., Wright, K., Armstrong, G., Baker, J., Pai-Panandiker, A., Kun, L., Patay, Z., Onar-Thomas, A., Ramachandran, A., Turner, D., Gajjar, A., S..., AACR-NCI-EORTC, Dublin, Ireland, 1/1/2012
• Tumor stem cells abrogate G1 arrest after ionizing radiation.
  Foy, A.B., Ye, H., Wetmore, C, AANS, San Diego, CA, 1/1/2009
• Pleomorphic Xanthoastrocytoma: A single institutional experience and review of literature.
  Nageswara Rao, A., Laack, N., Giannini, C, Wetmore, C, American Society for Pediatric Hematology/Oncology Annual meeting, 1/1/2009
• P53 independent abrogation of G1 arrest in tumor-derived neural stem like cells after exposure to ionizing radiation.
  Foy, A.B, Ye, H., Wetmore, C, World Federation of Neuro-Oncology, Yokohama, Japan, 1/1/2009
• Therapeutic doses of ionizing radiation damage the neural stem cell niche and impair hippocampal-dependent learning in the young mouse.
  Nageswara Rao, A.A., Howe, C., Ye, H., Choi, D.S., Wetmore, C, Society for Neuroscience Annual Meeting, 1/1/2009
• Abrogation of G1 arrest in murine brain tumor-derived stem like cells after ionizing radiation.
  Foy, A.B., Ye, H., Wetmore, C, AACR Annual meeting, San Diego, CA, 1/1/2008
• Mitotane Therapy for Intradural Spinal Adrenocortical Tumor in an Infant.
  Remberto C. Paulo, Vilmarie Rodriguez, Aida N. Lteif, Wetmore, C, Pediatric Academic Societies Annual meeting, 1/1/2008
• Bmi1- independent proliferation of stem cells derived from Hedgehog pathway –initiated medulloblastoma.
  Feddersen, R., Galvin, K.E., Ye, Hong, Wetmore, C, International Society of Pediatric Oncology (SIOP) Annual meeting, Mumbai, India, 1/1/2007
• Bmi1- independent proliferation of stem cells derived from Hedgehog pathway–initiated medulloblastoma.
  Feddersen, R., Galvin, K.E., Ye, Hong, Wetmore, C, Society for Neuro-oncology Annual Meeting, Dallas, TX, 1/1/2007
• Is Gli1 required for neural stem cell proliferation?
  Galvin, K.E., Ye, H., Wetmore, C, Society for Neuroscience Annual Meeting 2006, Atlanta, GA, 1/1/2006
• Modulation of Sonic hedgehog signaling in normal and tumor-derived neural stem cells.
  Galvin, K.E., Ye, H., Wetmore, C, EMBO Shh Workshop, Rome, Italy, 1/1/2006
• Modulation of Sonic hedgehog signaling in normal and tumor-derived neural stem cells.
  Galvin, K.E., Ye, H., Wetmore, C, Keystone Symposium "Cancer, stem cells and senescence", Singapore, Singapore, 1/1/2005
• Increased proliferation of neural progenitor cells in mice haploinsufficient for the Sonic hedgehog receptor, Patched*.
  Galvin, KE. Ye, Hong, Wetmore, C, Society for Neuroscience Annual Meeting, San Diego, CA, 1/1/2004
• Cellular and molecular consequences of Patched haploinsufficiency: analysis of differential gene expression during proliferation and differentiation of cerebellum.
  Leonard, JM, Baskerville, K., Ye, H., McKinney, M., Wetmore, C, Society for Neuroscience Annual Meeting, San Diego, CA, 1/1/2004
• Loss of p53 but not ARF or ATM accelerates medulloblastoma formation in mice heterozygous for patched.
  Wetmore, C., Eberhart, D., Curran, T, Platform presentation, American Association for Cancer Research Annual Meeting, New Orleans, LA, 1/1/2001
• Accelerated central nervous system tumorigenesis in mice with mutations in both patched and p53 genes.
  Wetmore, C., Curran, T, AACR Annual Meeting, San Francisco, CA, 1/1/2000
• Molecular analysis of brain tumors arising in mice heterozygous for patched mutations: a model for medulloblastoma.
  Wetmore, C., Curran, T, International Society for Pediatric Neuro-oncology, San Francisco, CA, 1/1/2000
• Tumorigenesis in mice heterozygous for patched mutations.
  Wetmore, C. Curran, T, AACR Annual Meeting, Philadelphia, PA, 1/1/1999
• Molecular and histologic analysis of brain tumors in mice heterozygous for patched mutations: a model for medulloblastoma.
  Wetmore, C., Curran, T, Platform presentation, Society for Neuro-Oncology Annual Meeting, Scottsdale, AZ, 1/1/1999
• Neurotrophin-3 immunoreactive nerve fibers innervate villi and blood vessels in rodent small intestine.
  Wetmore C, Vulchanova L, Olson L, US Society for Neuroscience Annual Meeting, 1/1/1995
• Kainate receptor mediated differential regulation of brain-derived neurotrophic factor mRNA and protein.
  Wetmore C, Bean AJ, Olson L, US Society for Neuroscience Annual Meeting, 1/1/1992
• Join now to see all

Lectures

• The Cancer Answer: Progress and Possibilities 
  Woodruff Arts Center, Atlanta, GA - 1/1/2014
• Research 101: Tissue acquisition and Bio-banking. 
  1/1/2014
• Bridging the Gap: Translating basic research into new approaches in clinical care. 
  Portsmouth, UK - 1/1/2013
• PDGFR signaling in diffuse pontine glioma. 
  Brain Tumor Center, Memorial Sloan Kettering Cancer Center, New York, NY - 1/1/2013
• DIPG: understanding heterogeneity in clinical presentation, biology and outcome. 
  1/1/2011
• Venous Thrombosis in Pediatric Brain Tumor Patients. 
  1/1/2011
• Mechanism and consequences of Shh pathway activation in response to ionizing radiation. 
  Toronto Hospital for Sick Children - 1/1/2010
• Oncologic Emergencies. 
  Vietnam - 1/1/2010
• Pediatric Brain Tumor Management. 
  Vietnam - 1/1/2010
• Cell-type specific Hedgehog signaling in neural progenitor cells. 
  1/1/2009
• Neurogenesis and cancer therapy: can we spare neural progenitor cells without sparing the tumor? 
  Mayo Clinic, Rochester, MN - 1/1/2009
• Preserving neurogenesis in survivors of pediatric cancer. 
  Memorial Sloan Kettering Cancer Center - 1/1/2008
• Hedgehog signaling in normal and neoplastic neural progenitor cells. 
  Karolinska Institute, Stockholm, Sweden - 1/1/2008
• Molecular control of neural progenitor cell proliferation. 
  Rochester, MN - 1/1/2008
• Hedgehog signaling in normal and neoplastic stem cells. 
  Dallas, TX - 1/1/2007
• Differential transduction of Sonic Hedgehog signaling in neural progenitor cells 
  New York, NY - 1/1/2007
• MD, PhD or MD, PhD: To be or not to be? 
  Mayo Graduate School, Rochester, MN, 2004, 2007 - 1/1/2007
• Modulation of Hedgehog signaling in normal and neoplastic neural stem cells. 
  Rochester, MN - 1/1/2007
• Molecular mechanisms of pediatric brain tumorigenesis. 
  Rochester, MN - 1/1/2007
• Molecular aberrations in pediatric brain tumors 
  Bethesda, MD - 1/1/2006
• Cell-type specific modulation of Hedgehog signaling: dysregulation in medulloblatoma. 
  M.D. Anderson Cancer Center, Houston, TX - 1/1/2006
• Hedgehog signaling in cancer and stem cells. 
  Rome, Italy - 1/1/2006
• Differential transduction of Hedgehog signaling in tumor stem cells. 
  University of Minnesota, Minneapolis, MN - 1/1/2006
• Dysregulation of Sonic hedgehog signaling in neural progenitor cells. 
  Children's National Medical Center, Washington, DC - 1/1/2005
• Molecular basis of pediatric brain tumors 
  Rome, Italy - 1/1/2005
• Join now to see all